• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Value-Based Cancer Care and the Excessive Cost of Drugs.

作者信息

Djulbegovic Benjamin

机构信息

USF Health Program for Comparative Effectiveness Research, Division for Evidence-Based Medicine, Department of Internal Medicine, University of South Florida, Tampa2Departments of Hematology and Health Outcome Behavior, H. Lee Moffitt Cancer Center & Rese.

出版信息

JAMA Oncol. 2015 Dec;1(9):1301-2. doi: 10.1001/jamaoncol.2015.3302.

DOI:10.1001/jamaoncol.2015.3302
PMID:26313294
Abstract
摘要

相似文献

1
Value-Based Cancer Care and the Excessive Cost of Drugs.基于价值的癌症护理与药品的高昂成本。
JAMA Oncol. 2015 Dec;1(9):1301-2. doi: 10.1001/jamaoncol.2015.3302.
2
Perspectives in Oncology Drug Pricing.肿瘤学药物定价的视角
JAMA Oncol. 2016 Mar;2(3):402. doi: 10.1001/jamaoncol.2015.5006.
3
Perspectives in Oncology Drug Pricing.肿瘤学药物定价的视角
JAMA Oncol. 2016 Mar;2(3):401-2. doi: 10.1001/jamaoncol.2015.5003.
4
Perspectives in Oncology Drug Pricing.肿瘤学药物定价视角
JAMA Oncol. 2016 Mar;2(3):401. doi: 10.1001/jamaoncol.2015.5000.
5
Perspectives in Oncology Drug Pricing-Reply.肿瘤学药物定价的观点——回应
JAMA Oncol. 2016 Mar;2(3):402-3. doi: 10.1001/jamaoncol.2015.4997.
6
Re: How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question.关于：生命价值几何：西妥昔单抗、非小细胞肺癌与那4400亿美元的问题。
J Natl Cancer Inst. 2010 Aug 4;102(15):1207; author reply 1207-10. doi: 10.1093/jnci/djq246. Epub 2010 Jul 22.
7
The "value" of immune-checkpoint inhibitors for advanced lung cancer.免疫检查点抑制剂对晚期肺癌的“价值”。
Respir Investig. 2017 Jul;55(4):253-254. doi: 10.1016/j.resinv.2017.04.001. Epub 2017 May 17.
8
Editorial: Comparative efficacy and cost associated with new agents in the treatment of non-small cell lung cancer (NSCLC).社论：与新药物治疗非小细胞肺癌（NSCLC）相关的疗效比较及成本
Lung Cancer. 2010 Aug;69 Suppl 1:S1-3. doi: 10.1016/S0169-5002(10)00330-2.
9
Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany.意大利和德国贝伐单抗与培美曲塞用于晚期非鳞状非小细胞肺癌的费用。
Lung Cancer. 2011 Feb;71(2):244; author reply 245. doi: 10.1016/j.lungcan.2010.10.004. Epub 2010 Nov 4.
10
Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs.纳武利尤单抗用于晚期鳞状非小细胞肺癌二线治疗的药物经济学视角
Clin Lung Cancer. 2017 Sep;18(5):e363-e365. doi: 10.1016/j.cllc.2017.04.007. Epub 2017 Apr 23.

引用本文的文献

1
How to Make Life and Death Medical Decisions? On the Occasion of Play/Drama as Health Care Protection Method of Decision Making Using by Patients with Pancreatic Cancer.如何做出关乎生死的医疗决策？论戏剧作为胰腺癌患者医疗决策保护方法的应用
Med Arch. 2023;77(3):170-172. doi: 10.5455/medarh.2023.77.170-172.
2
Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial.福沙吡坦与阿瑞匹坦预防接受顺铂化疗患者化疗引起的恶心和呕吐的多中心、随机、双盲、双模拟、阳性对照III期试验
Ann Transl Med. 2020 Mar;8(5):234. doi: 10.21037/atm.2019.12.158.
3
Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancer.
生物类似药候选药物 IBI305 联合紫杉醇/卡铂用于治疗非鳞状非小细胞肺癌。
Transl Lung Cancer Res. 2019 Dec;8(6):989-999. doi: 10.21037/tlcr.2019.12.23.
4
Rational decision making in medicine: Implications for overuse and underuse.医学中的理性决策：对过度使用和使用不足的影响。
J Eval Clin Pract. 2018 Jun;24(3):655-665. doi: 10.1111/jep.12851. Epub 2017 Dec 1.
5
Providing Doctors With High-Quality Information: An Updated Evaluation of Web-Based Point-of-Care Information Summaries.为医生提供高质量信息：基于网络的即时医疗信息摘要的最新评估
J Med Internet Res. 2016 Jan 19;18(1):e15. doi: 10.2196/jmir.5234.